Cinuperone

Cinuperone_structure.png

Cinuperone is a chemical compound that was investigated as a potential antipsychotic medication. It belongs to the class of butyrophenone derivatives, which are known for their use in the treatment of schizophrenia and other psychotic disorders.

Pharmacology

Cinuperone acts primarily as a dopamine receptor antagonist, similar to other butyrophenones such as haloperidol. By blocking dopamine receptors, particularly the D2 subtype, cinuperone can reduce the symptoms of psychosis, which are thought to be related to excessive dopaminergic activity in certain areas of the brain.

Clinical Trials

Although cinuperone showed promise in preclinical studies, it did not advance to widespread clinical use. The reasons for this could include insufficient efficacy, undesirable side effects, or the development of more effective alternatives. The specific outcomes of clinical trials involving cinuperone are not well-documented in the literature.

Side Effects

As with other antipsychotics, potential side effects of cinuperone may include extrapyramidal symptoms, such as tardive dyskinesia, akathisia, and parkinsonism. These side effects are due to the blockade of dopamine receptors in the nigrostriatal pathway.

Chemical Properties

Cinuperone is a butyrophenone derivative, characterized by a fluorophenyl group and a piperidine moiety. Its chemical structure is similar to that of other antipsychotics in its class, which contributes to its pharmacological activity.

History

The development of cinuperone occurred during a period of active research into new antipsychotic agents. While it did not become a marketed drug, its study contributed to the understanding of dopamine antagonists and their role in treating psychosis.

Also see

• Antipsychotic
• Butyrophenone
• Dopamine receptor antagonist
• Schizophrenia
• Haloperidol